Financhill
Back

Dianthus Therapeutics Quote, Financials, Valuation and Earnings

Dianthus Therapeutics Price Quote

$20.87
+0.10 (+-6.29%)
(Updated: November 21, 2024 at 5:04 AM ET)

Dianthus Therapeutics Key Stats

Sell
1
Dianthus Therapeutics (DNTH) is a Sell

Day range:
$20.53 - $22.45
52-week range:
$6.58 - $33.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
119.79
P/B ratio:
2.07%

Volume:
195K
Avg. volume:
273.4K
1-year change:
78.74%
Market cap:
$698.5M
Revenue:
$2.8M
EPS:
$-2.5

How Much Does Dianthus Therapeutics Make?

Is Dianthus Therapeutics Growing As A Company?

  • What Is Dianthus Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.35%
  • What Is Dianthus Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Dianthus Therapeutics Stock Price Performance

What Is Dianthus Therapeutics 52-Week High & Low?

Dianthus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Dianthus Therapeutics?

Is Dianthus Therapeutics Cash Flow Positive?

  • What Is DNTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$62.6M
  • What Is Dianthus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $211.1M
  • What Is Dianthus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$271.9M

Dianthus Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    DNTH return on invested capital is -23.69%
  • What Is Dianthus Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -22.7%
  • What Is DNTH Return On Equity?
    ROE is a measure of profitability and is -23.69%

Dianthus Therapeutics Earnings Date & Stock Price

Dianthus Therapeutics Competitors

Dianthus Therapeutics Dividend Yield

Dianthus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 135.07% 276.8%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 51.80
Upside from Last Price: 149.4%

Major Shareholders

  • How many DNTH shares are owned by institutional investors?
    38.8M DNTH shares are owned by institutional investors
  • How many DNTH shares are owned by insiders?
    4K DNTH shares are owned by insiders